Cabimed 74
ActiveSummary
Cabimed 74 has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €33,507 and a net result of €67,553. Equity is growing by ~10.3% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability100▲+7
Solvency41▲+3
Growth69▲+1
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000 at 30 days acceptable
Liquidity tight (current ratio 1.06 against 0.82 in 2023; short-term debt: 50.4% and cash: 11.5% of total assets), and 83.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
16.3%
Return on assets
32.8%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
35 d early
2024
20 d late
2023
23 d late
2022
31 d late
2021
2 d early
2020
31 d late
2019
8 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 9 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema, 2025 accounts filed, figures not processed yet
Turnover
€225,361▲ 7.6%
2023 · €209,388
EBIT margin
36.7%▲ 8.6pp
2023 · 28.2%
Net result
€67,553▲ 55.6%
2023 · €43,408
Working capital
€5,711
2023 · -€29,961
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Turnover€181,181€178,831▼ 1.3%€203,109▲ 13.6%€209,388▲ 3.1%€225,361▲ 7.6%
Operating result€37,690€37,029▼ 1.8%€58,329▲ 57.5%€58,945▲ 1.1%€82,802▲ 40.5%
Net result€28,254within the sector's middle half€26,745within the sector's middle half▼ 5.3%€44,086within the sector's middle half▲ 64.8%€43,408within the sector's middle half▼ 1.5%€67,553within the sector's middle half▲ 55.6%
EBIT margin20.8%20.7%▼ 0.1pp28.7%▲ 8.0pp28.2%▼ 0.6pp36.7%▲ 8.6pp
Equity€27,307below the sector's middle half€33,507below the sector's middle half▲ 22.7%€33,507below the sector's middle half=€33,507below the sector's middle half=€33,507below the sector's middle half=
Total assets€212,036within the sector's middle half▲ 0.7%€215,351within the sector's middle half▲ 1.6%€198,404within the sector's middle half▼ 7.9%€265,631within the sector's middle half▲ 33.9%€205,875within the sector's middle half▼ 22.5%
Debt€184,729▼ 12.6%€181,844▼ 1.6%€164,897▼ 9.3%€232,124▲ 40.8%€172,369▼ 25.7%
Working capital€16,055below the sector's middle half▲ 207%€22,766within the sector's middle half▲ 41.8%€24,959within the sector's middle half▲ 9.6%-€29,961below the sector's middle half€5,711below the sector's middle half
Solvency12.9%below the sector's middle half▲ 13.3pp15.6%below the sector's middle half▲ 2.7pp16.9%below the sector's middle half▲ 1.3pp12.6%below the sector's middle half▼ 4.3pp16.3%below the sector's middle half▲ 3.7pp
Current ratio1.44within the sector's middle half▲ 0.281.36below the sector's middle half▼ 0.081.33below the sector's middle half▼ 0.030.82below the sector's middle half▼ 0.511.06below the sector's middle half▲ 0.24
Return on assets (ROA)13.3%within the sector's middle half▲ 19.8pp12.4%within the sector's middle half▼ 0.9pp22.2%within the sector's middle half▲ 9.8pp16.3%within the sector's middle half▼ 5.9pp32.8%within the sector's middle half▲ 16.5pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2021 the operating result has climbed three years in a row; 2024 is 40% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €205,875
Fixed assets
€96,370 ▼ 25.8%
Current assets
€109,506 ▼ 19.4%
Equity and liabilities €205,875
Equity
€33,507 =
Debt
€172,369 ▼ 25.7%
Debt's share of the balance-sheet total falls from 87.4% to 83.7%. Debt is lower.
Key figures and ratios
EBITDA
€116,243▲
2023 · €81,802
Cash flow
€100,993▲
2023 · €66,265
Debt to equity
5.14▼
2023 · 6.93
ROE
201.6%▲
2023 · 129.6%
Interest coverage
55.51▼
2023 · 61.50
Debt ≤ 1 year
€103,794▼
2023 · €165,782
Debt > 1 year
€66,591▲
2023 · €64,358
Income taxes
€16,677▲
2023 · €15,063
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,713 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.
- Micro
- 5 to 10 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.8%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,713 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €181,181 | €178,831 | €203,109 | €209,388 | €225,361 | ▲ 7.6% |
| Non-recurring operating income76A | - | €0 | €600 | €0 | €0 | - |
| Goods, raw materials, services and sundry goods60/61 | - | €121,915 | €125,528 | €145,480 | €132,947 | ▼ 8.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €30,079 | €30,802 | €30,802 | €22,857 | €33,440 | ▲ 46.3% |
| Other operating charges640/8 | - | €403 | €448 | €655 | €5,859 | ▲ 795% |
| Gross operating margin9900 | €68,463 | €68,233 | €89,578 | €82,457 | €122,102 | ▲ 48.1% |
| Operating profit (loss)9901 | €37,690 | €37,029 | €58,329 | €58,945 | €82,802 | ▲ 40.5% |
| Financial income75/76B | - | €0 | €132 | €857 | €3,522 | ▲ 311% |
| Recurring financial income75 | €0 | €0 | €132 | €857 | €3,522 | ▲ 311% |
| Financial charges65/66B | - | €2,021 | €1,649 | €1,330 | €2,094 | ▲ 57.5% |
| Recurring financial charges65 | €2,127 | €2,021 | €1,649 | €1,330 | €2,094 | ▲ 57.5% |
| Profit (loss) for the period before taxes9903 | €35,564 | €35,008 | €56,812 | €58,472 | €84,230 | ▲ 44.1% |
| Income taxes67/77 | €7,310 | €8,263 | €12,726 | €15,063 | €16,677 | ▲ 10.7% |
| Profit (loss) for the period9904 | €28,254 | €26,745 | €44,086 | €43,408 | €67,553 | ▲ 55.6% |
| Profit (loss) for the period to be appropriated9905 | €28,254 | €26,745 | €44,086 | €43,408 | €67,553 | ▲ 55.6% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €212,036 | €215,351 | €198,404 | €265,631 | €205,875 | ▼ 22.5% |
| Fixed assets21/28 | €159,405 | €128,604 | €97,802 | €129,810 | €96,370 | ▼ 25.8% |
| Intangible fixed assets21 | €126,600 | €105,500 | €84,400 | €63,300 | €42,200 | ▼ 33.3% |
| Tangible fixed assets22/27 | €32,005 | €22,304 | €12,602 | €65,710 | €53,370 | ▼ 18.8% |
| Plant, machinery and equipment23 | - | €243 | €60 | €0 | - | - |
| Furniture and vehicles24 | - | €7,822 | €0 | - | €44,221 | - |
| Other tangible fixed assets26 | - | €14,240 | €12,543 | €10,846 | €9,149 | ▼ 15.6% |
| Assets under construction and advance payments27 | - | - | - | €54,865 | €0 | ▼ 100% |
| Financial fixed assets28 | €800 | €800 | €800 | €800 | €800 | = |
| Current assets29/58 | €52,630 | €86,747 | €100,601 | €135,821 | €109,506 | ▼ 19.4% |
| Amounts receivable after more than one year29 | - | - | €4,500 | €26,570 | €23,614 | ▼ 11.1% |
| Other amounts receivable291 | - | - | €4,500 | €26,570 | €23,614 | ▼ 11.1% |
| Amounts receivable within one year40/41 | €5,553 | €7,599 | €7,698 | €4,022 | €148 | ▼ 96.3% |
| Trade receivables40 | - | - | €1,000 | €1,000 | €0 | ▼ 100% |
| Other amounts receivable41 | - | €7,599 | €6,698 | €3,022 | €148 | ▼ 95.1% |
| Current investments50/53 | - | - | - | €53,000 | €57,615 | ▲ 8.7% |
| Cash at bank and in hand54/58 | €26,110 | €75,510 | €84,618 | €47,143 | €23,776 | ▼ 49.6% |
| Deferred charges and accrued income490/1 | - | €3,638 | €3,785 | €5,085 | €4,353 | ▼ 14.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €212,036 | €215,351 | €198,404 | €265,631 | €205,875 | ▼ 22.5% |
| Equity10/15 | €27,307 | €33,507 | €33,507 | €33,507 | €33,507 | = |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €14,907 | €14,907 | €14,907 | €14,907 | €14,907 | = |
| Non-distributable reserves130/1 | - | €1,860 | €0 | - | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €0 | - | - | - |
| Distributable reserves133 | - | €13,047 | €14,907 | €14,907 | €14,907 | = |
| Profit (loss) carried forward14 | €0 | €0 | €0 | €0 | €0 | - |
| Amounts payable17/49 | €184,729 | €181,844 | €164,897 | €232,124 | €172,369 | ▼ 25.7% |
| Amounts payable after more than one year17 | €146,167 | €115,878 | €87,269 | €64,358 | €66,591 | ▲ 3.5% |
| Financial debts170/4 | - | €115,878 | €87,269 | €64,358 | €66,591 | ▲ 3.5% |
| Amounts payable within one year42/48 | €36,575 | €63,981 | €75,643 | €165,782 | €103,794 | ▼ 37.4% |
| Current portion of amounts payable after more than one year42 | - | €30,290 | €28,608 | €22,912 | €30,897 | ▲ 34.9% |
| Financial debts43 | - | €833 | €0 | - | - | - |
| Credit institutions430/8 | - | €833 | €0 | - | - | - |
| Trade debts44 | €3,104 | €1,529 | €1,232 | €57,626 | €898 | ▼ 98.4% |
| Suppliers440/4 | - | €1,529 | €1,232 | €57,626 | €898 | ▼ 98.4% |
| Taxes, remuneration and social security45 | - | €2,579 | €1,717 | €10,730 | €4,173 | ▼ 61.1% |
| Taxes450/3 | - | €2,579 | €1,717 | €10,730 | €4,173 | ▼ 61.1% |
| Other amounts payable47/48 | - | €28,750 | €44,086 | €74,515 | €67,827 | ▼ 9.0% |
| Accrued charges and deferred income492/3 | - | €1,986 | €1,985 | €1,984 | €1,984 | = |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €28,254 | €26,745 | €44,086 | €43,408 | €67,553 | ▲ 55.6% |
| + Depreciation and write-downs630 | €30,079 | €30,802 | €30,802 | €22,857 | €33,440 | ▲ 46.3% |
| Operating cash flow (approximation) | €58,333 | €57,547 | €74,888 | €66,265 | €100,993 | ▲ 52.4% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€54,865 | €0 | ▲ 100% |
| Change in cash | - | €49,400 | €9,108 | -€37,474 | -€23,367 | ▲ 37.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
20-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 20 days late
2024
31-12
Financial
Highest result since 2018net €67,553 ▲55.6%
Operating result €82,802, net result €67,553, both a record.
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 23 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Back to profitnet €28,254
Net result €28,254 after 2 loss-making years.
23-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Weakest financial yearnet -€13,689
Net result drops to -€13,689, the lowest in the series; recovery starts the following year.
30-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
30-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 3 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Nivelles · 1 establishment unit since 2017
Ground area
765 m²
Building footprint
159 m²
Parcel 25072B0328/00N000, Wallonia. Linked by address, not a title deed.
4
companies at this address
See who is registered here
1 establishment unit
Mont Saint-Roch 32, 1400 Nivelles
since 20172.265.637.116
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25072B0328/00N000 | Wallonia | 765 m² | 1 · 159 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
648800BHTTNWXBBVL328
Similar companies · same sector, comparable size
AMLES
BE 1002.764.620
Stavelot · Eq €33,536
Doktershuis Hansbeke
BE 0737.615.021
Deinze · Eq €33,548
ANA CARE
BE 0795.651.210
Halle · Eq €33,587
Docteur Bien-Aimé
BE 0797.679.696
Nivelles · Eq €33,394
Docteur Damien Godart
BE 0536.547.283
Colfontaine · Eq €33,376
Of 9,130 companies in this sector we hold annual accounts for 6,339. 4,025 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded26-06-2017
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0677563014
Also
9925:BE0677563014
Registered
11-06-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.